CG Oncology Aims To Raise Up To $212M As It Sets IPO Terms
By Yeji Jesse Lee · January 18, 2024, 8:27 PM EST
Bladder-cancer therapy company CG Oncology set terms for its planned initial public offering Thursday, saying it intends to offer 11.8 million shares for between $16 and $18 per share, meaning it could...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login